What are the most valued startups in the XR market?
Download our beautiful pitch about the XR market

In our XR market deck, you will find everything you need to understand the market
The XR market is moving fast, with AI glasses, AR eyewear, medical visualization, VR training, and immersive entertainment companies competing for investor attention.
Because new rounds, acquisitions, and valuation signals appear regularly, we update this list every month to keep the ranking useful.
This page gives you a practical view of the most valuable XR startups today, ranked by their latest reported or estimated valuation.
And if you want to better understand this new industry, you can download our pitch covering the XR market.
A quick summary table
| Metric | Value |
|---|---|
| Most valuable XR startup | Sesame, with an estimated valuation of $1.7B–$3.1B |
| Second most valuable XR startup | XPANCEO, valued at $1.4B |
| Median XR startup valuation | About $65M |
| Share of XR valuation captured by the top 10 | About 59% |
| Top XR startup valuation vs. median | About 37x higher |
| Median XR valuation-to-capital-raised ratio | About 3.1x |
| XR startups valued at $1B+ | 7 startups |

This market map, featured in our XR market deck, highlights top companies and startups in the XR market
Top startups in the XR market ranked by valuation
Here is an updated table that ranks the top startups in the XR market based on their latest reported or estimated valuations.
If you want more detaild about their fundraising activity, you can check our list of the startups who have raised the most funding in the XR market.
| # | Startup Name | What They Do | Current Valuation ($) | Valuation Confidence Level | Valuation Type | Evidence Status | Total Funding ($) | Funding Confidence Level |
|---|---|---|---|---|---|---|---|---|
| 1 | Sesame | AI smart-glasses assistant | $1.7B–$3.1B | Strong Confidence | Implied Valuation from Raise | Implied | $298M | Strong Confidence |
| 2 | XPANCEO | Smart contact lenses | $1.4B | Full Confidence | Announced Private Round Valuation | Observed | $290M | Full Confidence |
| 3 | Magic Leap | Enterprise AR headsets | $1.0B–$1.6B | Partial Confidence | Proxy-Based Estimate | Estimated | $3.5B | Strong Confidence |
| 4 | RayNeo | Consumer AR smart glasses | $0.9B–$1.7B | Strong Confidence | Implied Valuation from Raise | Implied | $165M | Partial Confidence |
| 5 | XREAL | Consumer AR glasses | $1.0B–$1.3B | Strong Confidence | Announced Private Round Valuation | Observed | $433M | Strong Confidence |
| 6 | Rokid | AI AR glasses | $1.0B–$1.2B | Partial Confidence | IPO or Listing Range Valuation | Estimated | $512M | Partial Confidence |
| 7 | VITURE | XR display glasses | $700M–$1.2B | Partial Confidence | Implied Valuation from Raise | Implied | $222M | Strong Confidence |
| 8 | Osso VR | VR surgical training platform | $350M–$600M | Partial Confidence | Implied Valuation from Raise | Implied | $109M | Full Confidence |
| 9 | Sandbox VR | Location-based VR venues | $350M–$550M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $108M | Partial Confidence |
| 10 | Proprio | AI surgical visualization | $300M–$500M | Partial Confidence | Implied Valuation from Raise | Implied | $74M | Strong Confidence |
| 11 | Mojo Vision | Micro-LED displays | $320M–$420M | Partial Confidence | Implied Valuation from Raise | Implied | $343M | Strong Confidence |
| 12 | VRChat | Social VR world platform | $250M–$450M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $95M | Strong Confidence |
| 13 | Augmedics | AR spine surgical navigation | $250M–$450M | Low Confidence | Proxy-Based Estimate | Estimated | $146M | Strong Confidence |
| 14 | Varjo | Enterprise XR headsets | $240M–$320M | Partial Confidence | Comparables-Based Estimate | Estimated | $149M | Strong Confidence |
| 15 | Augmodo | Spatial AI retail wearables | $190M–$310M | Partial Confidence | Implied Valuation from Raise | Implied | $43M | Full Confidence |
| 16 | IXI | Autofocus adaptive eyewear | $180M–$300M | Strong Confidence | Implied Valuation from Raise | Implied | $41M | Strong Confidence |
| 17 | Neurable | Everyday BCI wearables | $175M–$290M | Partial Confidence | Implied Valuation from Raise | Implied | $56M | Partial Confidence |
| 18 | Immersed | VR workspaces and Visor | $170M–$260M | Low Confidence | Active Raise Valuation | Estimated | $12M | Low Confidence |
| 19 | TRANSFR | VR workforce training | $160M–$260M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $90M | Strong Confidence |
| 20 | XYZ Reality | AR construction delivery | $140M–$230M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $35M | Full Confidence |
| 21 | Avegant | Light-field displays | $150M–$210M | Partial Confidence | Announced Private Round Valuation | Estimated | $94M | Partial Confidence |
| 22 | TechSee | Visual AI customer support | $120M–$220M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $54M | Full Confidence |
| 23 | FundamentalVR | Haptic VR surgical simulation | $120M–$220M | Partial Confidence | Implied Valuation from Raise | Implied | $27M | Strong Confidence |
| 24 | Interplay Learning | VR skilled-trades training | $120M–$220M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $47M | Strong Confidence |
| 25 | MediView XR | AR surgical imaging navigation | $120M–$200M | Strong Confidence | Implied Valuation from Raise | Implied | $24M | Full Confidence |
| 26 | Pixee Medical | AR orthopedic surgery guidance | $110M–$190M | Partial Confidence | Implied Valuation from Raise | Implied | $17M | Full Confidence |
| 27 | STRIVR | Enterprise VR training | $110M–$190M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $86M | Full Confidence |
| 28 | RealWear | Industrial assisted reality | $120M–$180M | Low Confidence | Proxy-Based Estimate | Estimated | $122M | Partial Confidence |
| 29 | Medivis | AR surgical navigation platform | $110M–$180M | Partial Confidence | Implied Valuation from Raise | Implied | $22M | Strong Confidence |
| 30 | HaptX | Realistic haptic VR gloves | $100M–$180M | Partial Confidence | Implied Valuation from Raise | Estimated | $54M | Partial Confidence |
| 31 | INMO | Lightweight AR smart glasses | $90M–$180M | Partial Confidence | Comparables-Based Estimate | Estimated | $25M | Partial Confidence |
| 32 | Loft Dynamics | VR aviation simulator training | $120M–$150M | Strong Confidence | Implied Valuation from Raise | Implied | $20M | Full Confidence |
| 33 | Resolution Games | VR game developer | $100M–$160M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $39M | Full Confidence |
| 34 | Pimax | Wide-FOV VR headsets | $90M–$160M | Partial Confidence | Implied Valuation from Raise | Implied | $83M | Partial Confidence |
| 35 | Mursion | VR workplace simulations | $90M–$150M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $41M | Partial Confidence |
| 36 | Bigscreen | Social VR cinema platform | $80M–$150M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $14M | Full Confidence |
| 37 | XRSpace | Social VR metaverse platform | $80M–$150M | Partial Confidence | Implied Valuation from Raise | Estimated | $40M | Partial Confidence |
| 38 | nDreams | VR games developer-publisher | $110M | Full Confidence | Acquisition Value | Observed | $47M | Strong Confidence |
| 39 | Survios | VR game studio | $70M–$120M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $71M | Partial Confidence |
| 40 | Holo-Light | XR pixel streaming | $75M–$115M | Partial Confidence | Implied Valuation from Raise | Implied | $33M | Partial Confidence |
| 41 | ArborXR | XR device management | $65M–$95M | Strong Confidence | Implied Valuation from Raise | Implied | $25M | Partial Confidence |
| 42 | Emerge | Bare-hand immersive touch | $50M–$100M | Partial Confidence | Implied Valuation from Raise | Estimated | $31M | Strong Confidence |
| 43 | Upskill | Enterprise AR work platform | $50M–$100M | Low Confidence | Acquisition Value | Estimated | $53M | Partial Confidence |
| 44 | Zero Latency | Free-roam VR venues | $45M–$95M | Low Confidence | Proxy-Based Estimate | Estimated | $6M | Partial Confidence |
| 45 | frontline.io | Industrial XR digital twins | $55M–$85M | Strong Confidence | Implied Valuation from Raise | Implied | $10M | Full Confidence |
| 46 | XRHealth | XR virtual healthcare clinics | $45M–$90M | Partial Confidence | Implied Valuation from Raise | Implied | $27M | Partial Confidence |
| 47 | Safe Dynamics | VR safety training systems | $35M–$100M | Low Confidence | IPO or Listing Range Valuation | Estimated | $7M | Low Confidence |
| 48 | SideQuest | VR app distribution | $50M–$85M | Partial Confidence | Implied Valuation from Raise | Implied | $16M | Full Confidence |
| 49 | Ultraleap | Hand tracking and haptics | $40M–$90M | Partial Confidence | Acquisition Value | Estimated | $166M | Strong Confidence |
| 50 | bHaptics | XR haptic wearables | $45M–$85M | Partial Confidence | Implied Valuation from Raise | Implied | $15M | Partial Confidence |
| 51 | Campfire | Holographic design collaboration | $40M–$80M | Partial Confidence | Proxy-Based Estimate | Estimated | $8M | Strong Confidence |
| 52 | Dreamscape Immersive | Immersive VR attractions | $35M–$75M | Low Confidence | Revenue or ARR Multiple Estimate | Estimated | $72M | Partial Confidence |
| 53 | Scope AR | Enterprise AR work instructions | $30M–$75M | Low Confidence | Comparables-Based Estimate | Estimated | $12M | Full Confidence |
| 54 | AmazeVR | VR concert platform | $35M–$70M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $49M | Strong Confidence |
| 55 | Alta | Multiplayer VR RPG studio | $40M–$70M | Partial Confidence | Announced Private Round Valuation | Implied | $12M | Full Confidence |
| 56 | Taqtile | AR frontline work instructions | $35M–$75M | Low Confidence | Comparables-Based Estimate | Estimated | $8M | Partial Confidence |
| 57 | Strolll | AR neurorehabilitation software | $45M–$60M | Strong Confidence | Announced Private Round Valuation | Observed | $16M | Partial Confidence |
| 58 | SentiAR | AR cardiac visualization | $35M–$65M | Partial Confidence | Implied Valuation from Raise | Implied | $17M | Partial Confidence |
| 59 | LIV | Mixed-reality streaming | $35M–$60M | Partial Confidence | Implied Valuation from Raise | Implied | $12M | Partial Confidence |
| 60 | Polyarc | VR game studio | $35M–$60M | Partial Confidence | Implied Valuation from Raise | Implied | $18M | Strong Confidence |
| 61 | ShapesXR | XR design collaboration | $35M–$55M | Partial Confidence | Implied Valuation from Raise | Implied | $9M | Full Confidence |
| 62 | Wave | Virtual concert platform | $25M–$65M | Low Confidence | Proxy-Based Estimate | Estimated | $43M | Partial Confidence |
| 63 | TRIPP | XR wellness app | $30M–$55M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $26M | Strong Confidence |
| 64 | VRAI | Simulation training analytics | $30M–$50M | Partial Confidence | Implied Valuation from Raise | Implied | $10M | Partial Confidence |
| 65 | Aircards | Immersive brand experience studio | $27M–$50M | Partial Confidence | Implied Valuation from Raise | Implied | $4M | Full Confidence |
| 66 | Tilt Five | Tabletop AR gaming system | $30M–$45M | Partial Confidence | Comparables-Based Estimate | Estimated | $21M | Partial Confidence |
| 67 | VoxelSensors | Low-power 3D sensors | $25M–$50M | Partial Confidence | Implied Valuation from Raise | Estimated | $10M | Strong Confidence |
| 68 | Fast Travel Games | VR games publisher | $25M–$45M | Partial Confidence | Implied Valuation from Raise | Implied | $10M | Full Confidence |
| 69 | PrecisionOS | VR surgical training | $25M–$45M | Low Confidence | Revenue or ARR Multiple Estimate | Estimated | $2M | Strong Confidence |
| 70 | Talespin | XR immersive learning | $25M–$45M | Partial Confidence | Acquisition Value | Estimated | $40M | Strong Confidence |
| 71 | ImmersiveTouch | Surgical XR planning platform | $20M–$45M | Low Confidence | Acquisition Value | Estimated | $1M | Partial Confidence |
| 72 | Immertec | Immersive surgical training | $22M–$40M | Low Confidence | Comparables-Based Estimate | Estimated | $12M | Partial Confidence |
| 73 | SenseGlove | XR haptic gloves | $20M–$40M | Partial Confidence | Implied Valuation from Raise | Implied | $6M | Partial Confidence |
| 74 | Brilliant Labs | Open-source AI glasses | $20M–$40M | Low Confidence | Implied Valuation from Raise | Implied | $6M | Partial Confidence |
| 75 | Virti | AI immersive training | $20M–$40M | Low Confidence | Implied Valuation from Raise | Estimated | $10M | Partial Confidence |
| 76 | Thirdverse | XR game studio | $20M–$40M | Low Confidence | Implied Valuation from Raise | Implied | $42M | Partial Confidence |
| 77 | CUREosity | VR rehabilitation therapy | $20M–$35M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $9M | Strong Confidence |
| 78 | Felix & Paul Studios | Cinematic VR storytelling | $18M–$35M | Low Confidence | Comparables-Based Estimate | Estimated | $7M | Full Confidence |
| 79 | Arthur | VR collaboration workspace | $18M–$35M | Low Confidence | Comparables-Based Estimate | Estimated | $6M | Strong Confidence |
| 80 | Manus | XR motion-capture gloves | $15M–$35M | Low Confidence | Proxy-Based Estimate | Estimated | $3M | Low Confidence |
| 81 | Rendever | VR senior-care wellness | $18M–$30M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $4M | Low Confidence |
| 82 | ForeVR Games | Casual VR sports games | $15M–$30M | Low Confidence | Revenue or ARR Multiple Estimate | Estimated | $19M | Strong Confidence |
| 83 | The Wild | XR AEC collaboration | $10M–$30M | Low Confidence | Acquisition Value | Estimated | $3M | Low Confidence |
| 84 | Almer Technologies | Industrial AR smart glasses | $12M–$24M | Partial Confidence | Acquisition Value | Estimated | $12M | Partial Confidence |
| 85 | Emteq | Emotion-sensing smart eyewear | $10M–$25M | Low Confidence | Proxy-Based Estimate | Estimated | $3M | Low Confidence |
| 86 | Mira | Lightweight AR headsets | $10M–$25M | Low Confidence | Acquisition Value | Estimated | $17M | Partial Confidence |
| 87 | Nanome | VR molecular design | $12M–$22M | Low Confidence | Revenue or ARR Multiple Estimate | Estimated | $3M | Partial Confidence |
| 88 | Condense | 3D live-event streaming | $12M–$22M | Partial Confidence | Implied Valuation from Raise | Implied | $6M | Partial Confidence |
| 89 | Bodyswaps | VR soft-skills training | $10M–$18M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $1M | Partial Confidence |
| 90 | Sense Arena | VR sports training | $9M–$18M | Low Confidence | Comparables-Based Estimate | Estimated | $3M | Partial Confidence |
| 91 | ManageXR | XR device management | $9M–$16M | Partial Confidence | Revenue or ARR Multiple Estimate | Estimated | $4M | Full Confidence |
| 92 | VictoryXR | Immersive education metaversities | $8M–$15M | Low Confidence | Implied Valuation from Raise | Estimated | $3M | Partial Confidence |
| 93 | XR Games | VR game studio | $7M–$16M | Low Confidence | Proxy-Based Estimate | Estimated | $14M | Partial Confidence |
| 94 | RETìníZE | VR animation software | $8M–$14M | Partial Confidence | Implied Valuation from Raise | Implied | $4M | Strong Confidence |
| 95 | Glue | VR collaboration platform | $5M–$15M | Low Confidence | Acquisition Value | Estimated | $4M | Partial Confidence |
| 96 | Rec Room | Social VR gaming | $0M–$10M | Partial Confidence | Proxy-Based Estimate | Estimated | $294M | Strong Confidence |
| 97 | Lynx | Mixed-reality headsets | $0M–$5M | Low Confidence | Proxy-Based Estimate | Estimated | $7M | Strong Confidence |

This chart, featured in our XR market deck, compares the 2026 size of the XR market with other markets of similar size
Key valuation trends in the XR market
Insights
- XR startup value is highly concentrated. The top 10 companies represent about 59% of the full ranking’s estimated value, which shows how much the market depends on a small set of category leaders.
- AI glasses, AR glasses, and smart lenses dominate the top of the XR market. Sesame, XPANCEO, RayNeo, XREAL, Rokid, and VITURE together represent more than $8B of estimated value.
- Medical and surgical XR is one of the strongest specialist clusters. Osso VR, Proprio, Augmedics, MediView XR, Pixee Medical, Medivis, and related companies show that healthcare can support serious XR valuations.
- Some smaller XR startups show very strong capital efficiency. frontline.io, IXI, Loft Dynamics, MediView XR, and Pixee Medical all sit far above the market median on valuation compared with total funding raised.
- Consumer social VR and gaming companies are valuable, but the ranking suggests a ceiling below the leading eyewear companies. VRChat, Resolution Games, nDreams, Survios, Bigscreen, and Polyarc remain meaningful but smaller.
- The median XR startup in this ranking is valued at about $65M, which is far below Sesame’s estimated midpoint of $2.4B. This gap shows how unequal value creation has become in XR.

This chart, featured in our XR market deck, looks at XREAL’s strategy in XR
A few word about our methodology
As you can see, we built a database that ranks startups in the XR market based on their current valuation.
Estimating startup valuations is not always straightforward. Many XR companies do not publicly disclose their valuation, and the available information can vary widely depending on the company and its stage.
To build this ranking, we applied a structured valuation methodology and cross-checked information across multiple reliable sources.
Whenever possible, we relied on direct disclosures. These include announced valuations from completed funding rounds, public filings for listed companies, or official acquisition prices.
When an XR startup is publicly listed, we use its current market capitalization as the reference valuation.
If an XR company was acquired and no independent valuation can reasonably be estimated today, we use the acquisition price as the main reference point.
When an XR startup recently raised capital but the valuation was not disclosed, we estimate the implied valuation using typical dilution levels for that stage of fundraising.
In some cases, we also estimate valuations using operating metrics such as revenue, ARR, or customer traction, combined with valuation multiples from comparable companies in the same market.
When direct financial data is not available, we may rely on carefully selected comparable startups and other signals such as hiring growth, investor quality, product traction, enterprise adoption, headset shipments, clinical adoption, or consumer usage.
All estimates follow a strict evidence hierarchy. Recent funding rounds with announced valuations carry the most weight, followed by strong operating metrics and comparable company analysis.
We also carefully evaluate the age of every data point. Recent information carries more weight, while older data is treated cautiously and adjusted conservatively when necessary.
Whenever information is uncertain or incomplete, we clearly distinguish between confirmed facts and reasonable inferences.
Because valuation data is not always fully public, each XR startup in the ranking is assigned a confidence level based on the reliability, recency, and consistency of the available evidence.
Full confidence means the valuation is supported by strong and recent evidence. Strong confidence means the estimate is well supported but includes minor inference. Partial confidence means the estimate relies more heavily on indirect signals. Low confidence means available information is limited or inconsistent.
When confidence is lower, we take a more conservative approach by widening the valuation range. This helps reflect the uncertainty and increases the probability that the true valuation falls within the estimated range.
This reflects how we conduct all our research, including the work behind our report covering the XR market.
In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.
If you want the full detail on a specific valuation estimate, feel free to contact us and we will gladly explain.
Finally, know that we update the dataset once per month, so come back here if you need fresh information.

This chart, featured in our XR market deck, illustrates yearly funding for XR startups
Related blog posts
- The most recent news in the XR market
- The most recent funding news in the XR market
- What has changed recently in the XR market?
- The evolution of funding activity in the XR market
- The main fundraising trends in the XR market
Who is the author of this content?
NEW MARKET PITCH TEAM
We track new markets so founders and investors can move fasterWe build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.
How we created this content 🔎📝
At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.
So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.
Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.